GLAXONSEGlaxoSmithKline Pharmaceuticals Limited· Pharmaceuticals & BiotechnologyHighNeutral
Announced Thu, 6 Nov, 2025 · 16:12 IST

Quarterly profit rises 2% as revenue falls 3%; Nashik solar project approved

Revenue DeclineEbitda Margin ExpansionExceptional ItemResults View source PDFExplain this filing

GLAXO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.3%Reaction day
₹2578.00
prior close
₹2605.50
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)+0.5%-0.2% vs market
Pharmaceuticals peers, median of 156sector-0.1%+0.3% vs sector

On the reaction day the stock moved 0.2 pts less than Nifty Midcap 150 and 0.3 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-1.2
10m
-1.9
15m
-2.3
30m
-2.7
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.3+0.5-0.2-0.1+0.3
Next day
-1.5+0.9-2.4-0.7-0.8
2d
-3.9+1.4-5.3-0.9-3.0
3d
-3.0+2.1-5.1+0.1-3.1
4d
-3.2+1.8-5.0+0.2-3.4
5d
-3.9+1.9-5.8+0.0-3.9
1w
-3.4+1.9-5.3-0.3-3.1
15d
-0.3+2.2-2.5-1.7+1.4
1m
-1.7-0.4-1.3-5.4+3.6
2m
-4.8+3.1-7.9-2.8-2.0
3m
-2.4+1.6-4.0-7.4+4.9
UpDownMarket · Nifty Midcap 150Sector · Pharmaceuticals peers, median of 156Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Quarter revenue fell 3.1% to Rs 97,994 lakh; profit rose 2.0% to Rs 25,749 lakh. Six-month revenue fell 2.2% to Rs 178,511 lakh; profit rose 6.4% to Rs 46,250 lakh. Operating cash flow totaled Rs 18,374 lakh. Revenue margin before interest, tax, depreciation and amortization rose to 37.7% from 35.2%. Board approved Rs 1.74 crore for a 26% stake in a 4.95 MW Nashik solar project. Exceptional credit: Rs 264 lakh property-sale gain.

Likely market impact

Higher profit, wider margins and positive cash flow may support the stock, but lower sales and a one-off property gain temper the outlook.